Drugs / CP-195543
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00424294 | Jun 2006 → Dec 2007 | rheumatoid arthritis | Pfizer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CP-195543 | “CP-195543 is a potent and specific antagonist of the leukotriene B4 (LTB4) receptor.” NCT00424294 ↗ |
| Action | Inhibit | “potent and specific antagonist” NCT00424294 ↗ |
| Modality | Small molecule | — CHEMBL301829 ↗ |